BIOFORCE NANOSCIENCES HOLDINGS, INC. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/42de9ecd-7eb6-440e-8e9c-117f0c97548e/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-1.3M | 2025-01-01 – 2025-12-31 | evidence 0001091818-26-000047 |
| FY 2024 | $-490.4k | 2024-01-01 – 2024-12-31 | evidence 0001091818-25-000036 |
| FY 2023 | $-472.0k | 2023-01-01 – 2023-12-31 | evidence 0001091818-24-000034 |
| FY 2022 | $-485.5k | 2022-01-01 – 2022-12-31 | evidence 0001091818-23-000044 |
| FY 2021 | $-502.0k | 2021-01-01 – 2021-12-31 | evidence 0001091818-22-000014 |
| FY 2020 | $-158.4M | 2020-01-01 – 2020-12-31 | evidence 0001091818-21-000016 |
| FY 2019 | $-46.5k | 2019-01-01 – 2019-12-31 | evidence 0001091818-20-000036 |
| FY 2018 | $-67.7k | 2018-01-01 – 2018-12-31 | evidence 0001091818-19-000088 |
| FY 2017 | $-31.3k | 2017-01-01 – 2017-12-31 | evidence 0001091818-19-000088 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
BIOFORCE NANOSCIENCES HOLDINGS, INC. — all facts · Revenue · Operating Income